[3P] Alzheimer's Disease and Dementia

[3P-212] Cannabinoid receptor type II in microglia as a therapeutic target for Alzheimer's disease

*Akira Sobue¹, Okiru Komine¹, Fumito Endo¹, Shigeo Murayama², Takashi Saito³, Takaomi Saido⁴, Koji Yamanaka¹ (1.Dept of Neurosci. and Pathobiol., RIEM, Nagoya Univ., Nagoya, Japan, 2.Dept of Neuropathol., Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Tokyo, Japan, 3.Department of Neurocognitive Science, Nagoya City University, Nagoya, Japan, 4.Laboratory for Proteolytic Neuroscience, RIKEN Center for Brain Science, Wako, Japan)